M&A Deal Summary |
|
---|---|
Date | 2002-01-01 |
Target | Joma-Polytec |
Sector | Chemicals |
Buyer(s) | BWK GMBH |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1990 |
PE ASSETS | 300M EUR |
Size | Middle-Market |
Type | Sector Agnostic |
BWK GMBH is a private equity firm focused on lower middle-market acquisitions and investments. The Firm looks to invest €5 to€30 million in companies with at least €10 to million €100 in revenue. Prospective transaction situations include buyouts, growth capital financings, and recapitalizations. BWK does not have any sector preferences, however, the Firm will not consider venture investments or turnaround situations. BWK GMBH is based in Stuttgart, Germany.
DEAL STATS | # |
---|---|
Overall | 3 of 26 |
Sector (Chemicals) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 1 of 8 |
Country (Germany) | 3 of 25 |
Year (2002) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
1999-01-01 |
IMS Gear SE KGaA
Donaueschingen, Germany IMS Gear SE & Co. KGaA is a manufacturer of drive elements for use in the automotive sector for actuators in the engine compartment and interior of vehicles. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2004-01-01 |
R-Biopharm AG
Darmstadt, Germany R-Biopharm AG engages in developing, producing, and selling diagnostic products in the fields of clinical diagnostics and food analysis. For clinical diagnostics, test kits for infection and allergy diagnostics as well as gastroenterological questions in diagnostics and drug monitoring are offered. The portfolio for food analysis includes tests for the detection of allergens, mycotoxins, unauthorized drug residues, product adulteration, and ingredients (vitamins, sugar, acids) in food and feed. |
Buy | - |